NCT05516914 2026-04-01
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Completed
Nanjing Leads Biolabs Co.,Ltd
RemeGen Co., Ltd.
Traws Pharma, Inc.
Lixte Biotechnology Holdings, Inc.
INSYS Therapeutics Inc